2011 Fiscal Year Final Research Report
Inhibitory effects of exercise on progression of obesity-related liver diseases and development of glyco-biomarkers to scale the pathophysiology of the liver diseases
Project/Area Number |
22650162
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Applied health science
|
Research Institution | University of Tsukuba |
Principal Investigator |
SHODA Junichi 筑波大学, 医学医療系, 教授 (90241827)
|
Co-Investigator(Kenkyū-buntansha) |
AJISAKA Ryuichi 筑波大学, 体育系, 教授 (70151058)
FUKUDA Kuniaki 筑波大学, 医学医療, 講師 (50447257)
OKAMOTO Yoshikazu 筑波大学, 医学医療, 講師 (90420083)
|
Project Period (FY) |
2010 – 2011
|
Keywords | 肥満 / 脂肪性肝疾患 / 運動療法 / 糖鎖医学 / バイオマーカー |
Research Abstract |
In management of obesity-related liver diseases, that is, non-alcoholic fatty liver diseases, it is important to increase a utilization of glucose in the skeletal muscles and thereby to improve the insulin-resistance. Therefore, in subjects with non-alcoholic fatty liver diseases, it is also important to maintain the volume of skeletal muscles by appropriate exercise. In the assessment of effects of exercise on liver pathophysiology of non-alcoholic fatty liver diseases, we need to explore novel biomarkers that can reflect the status of liver pathophysiology in terms of steatosis, inflammation, and fibrosis, and to develop a non-invasive measurement system of these biomarkers. In this research project, using the serum samples of middle-aged obese men who joined a weight-losing course, we explored novel biomarkers that can scale the improvement of liver pathophysiology induced by exercise. We measured an enzyme activity of N-acetylglucosaminyltransferase V (GnT-V) in the serum samples as a glyco-biomaker. Exercise increased the energy consumption, maintained the lean body mass, and decreased the serum levels of ferritin and TBARS, an oxidative stress marker, in comparison with diet restriction. Taken together, it is likely that serum levels of ferritin and TBARS are useful biomarkers to scale the effects of exercise on liver pathophysiology in obese men. Exploration of novel glycol-biomarkers is being performed.
|
-
[Journal Article] Orexin 2 receptioor as a potential target for the immunotoxin and antibody-drug conjugate cancer tgherapy2012
Author(s)
Kishida M, Ishige, K., Horibe, T., Tada, N., Koibuchi, N., Shoda J, Kita, K., Kawakami, K
-
Journal Title
Oncology Letters
Volume: 3
Pages: 525-529
-
-
[Journal Article] Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tarct2011
Author(s)
Nakayama, H., Sugahara, S., Fukuda, K., Abei, M., Shoda, J., Tokita, M., Sakurai, H., Tsuboi, K., Matsuzaki, Y., Tokuue, K
-
Journal Title
Int J Radiat Oncol Biol Phys
Volume: 80
Pages: 992-995
-
[Journal Article] Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells2011
Author(s)
Sugiyama, H., Onuki, K., Ishige, K., Baba, N., Ueda, T., Matsuda, S., Takeuchi, K., Onodera, M., Nakanuma, Y., Yamato, M., Yamamoto, M., Hyodo, I., Shoda, J
-
Journal Title
J Gastroenterol
Volume: 46
Pages: 779-789
-
[Journal Article] WFA-positive sialylated MUC1 is a high-sensitivity biliary marker for intrahepatic cholangiocarcinoma2010
Author(s)
Matsuda, A., Kuno, A., Kawamoto, K., Matsuzaki, H., Irimura, T., Ikehara, Y., Zen, Y., Nakanuma, Y., Yamamoto, M., Ohkohchi, N., Shoda, J., Hirabayashi, J., Narimatsu, H
-
Journal Title
Hepatology
Volume: 52
Pages: 174-182
-
[Journal Article] S-1化学療法が奏効し根治手術が可能となったStage IVb進行胆嚢癌の1例2010
Author(s)
長谷川直之, 安倍井誠人, 佐々木亮孝, 朴秀吉, 森脇俊和, 南優子, 福田邦明, 平井祥子, 正田純一, 大河内信弘, 兵頭一之介
-
Journal Title
胆道学会誌
Volume: 24
Pages: 723-728
-
[Journal Article] Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice2010
Author(s)
Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., Taguchi, K., Yanagawa, T., Nakahara, A., Hyodo, I., Ishii, T., Yamamoto, M
-
Journal Title
Am J Physiol
Volume: 298
Pages: G283-G294
-
[Journal Article] Proton beam therapy for large hepatocellular carcinoma2010
Author(s)
Sugahara, S., Oshiro, Y., Nakayama, H., Fukuda, K., Mizumoto, M., Abei, M., Shoda, J., Matsuzaki, Y., Tohno, E., Tokita, M., Tsuboi, K., Tokuue, K
-
Journal Title
Int J Radiat Oncol Biol Phys
Volume: 76
Pages: 460-466
-
-
[Journal Article] Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis
Author(s)
Okada K, Warabi E, Sugimoto H, Horie M, Tokushige K, Ueda T, Harada N, Taguchi K, Hashimoto E, Itoh K, Ishii T, Utsunomiya H, Yamamoto M, Shoda J
-
Journal Title
J Gastroenterol 2012
Volume: (In press)
-
[Presentation] 胆管がん診断へ向けた新たなコンビネーション診断系の確立2011
Author(s)
松田厚志, 久野敦, 松崎英樹, 川本徹, 鹿内俊秀, 中沼安二, 山本雅一, 大河内信弘, 池原譲, 正田純一, 平林淳, 成松久
Organizer
第31回日本分子腫瘍マーカー研究会
Year and Date
20111000
-
-
-
-
-
-
-
-
[Presentation] Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice2010
Author(s)
Okada K, Sugimoto H, Shoda J, Warabi E, Ishige K, Ueda T, Taguchi K, Yanagawa T, Nakahara A, Hyodo I, Ishii T, Yamamoto M
Organizer
The 2nd International Forum
Place of Presentation
Niigata, Japan
Year and Date
20100400
-
-
[Book] NOVA Science Publishers2012
Author(s)
Shoda, J., Kawamoto T, Yamamoto, M
Publisher
Gallbladder Cancer-Pathogenesis and Molecular Targeting Strategies for Therapeutic Options. In : Gallbladder Cancer, Christopher V Aiello, ed(In press)
-
-
-